Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001599298-24-000150
Filing Date
2024-10-15
Accepted
2024-10-15 17:08:13
Documents
1
Period of Report
2024-10-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1729026485.html 4  
1 FORM 4 wk-form4_1729026485.xml 4 4046
  Complete submission text file 0001599298-24-000150.txt   5682
Mailing Address C/O PHARMACYCLICS, INC. 995 EAST ARQUES AVE. SUNNYVALE CA 94085
Business Address
Clark Kenneth A (Reporting) CIK: 0001561736 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36866 | Film No.: 241372604

Mailing Address 601 BRICKELL KEY DRIVE SUITE 1000 MIAMI FL 33131
Business Address 601 BRICKELL KEY DRIVE SUITE 1000 MIAMI FL 33131 305-203-2034
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

EIN.: 371979717 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)